Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award

Published on by Global Diseases Research

Dr. Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award 

Lecturer | Univeristy of the Witwatersrand | South Africa

Dr. Raeesa Manjoo-Docrat is a developing scholar affiliated with the University of the Witwatersrand, Johannesburg, whose work contributes to the advancement of quantitative epidemiology and public health modelling in South Africa. Her research focuses on the development and application of spatial, age-stratified epidemiological models aimed at understanding disease transmission dynamics within heterogeneous populations. With four peer-reviewed publications and 27 citations, she has established a growing academic footprint supported by an h-index of 2, reflecting the early but significant influence of her work. Her recent open-access article in Heliyon (2025), which applies spatial modelling frameworks to the South African COVID-19 pandemic, exemplifies her commitment to integrating mathematical rigor with real-world public health challenges. Manjoo-Docrat has collaborated with multidisciplinary teams comprising epidemiologists, mathematicians, and public health scientists, enabling her to contribute to robust analytical frameworks and high-quality scientific outputs. These collaborations also highlight her ability to operate effectively within diverse research environments and to engage in evidence-based problem solving that supports both academic and policy-relevant outcomes. Her research sits at the intersection of infectious disease dynamics, health systems planning, and data-driven decision support, positioning her work within a globally relevant domain of applied epidemiology. Beyond academic metrics, her contributions have societal impact by informing approaches to epidemic preparedne  ss, guiding interventions for vulnerable demographic groups, and enhancing understanding of spatial disparities in health outcomes. Through her continued scholarship, Manjoo-Docrat aims to strengthen the integration of mathematical modelling into national and regional public health strategies, ensuring that data-informed insights contribute to improved health resilience and equitable disease control.

Profiles: Scopus | ORCID

Featured Publications

1. Manjoo-Docrat, R., Abdelatif, N., Holloway, J., Dudeni-Tlhone, N., Dresselhaus, C., Mbayise, E., … Makhanya, S. (2025). Spatial age-stratified epidemiological model with applications to South African COVID-19 pandemic. Heliyon, 11(11), e43171. https://doi.org/10.1016/j.heliyon.2025.e43171

2. Dresselhaus, C., Fabris-Rotelli, I., Manjoo-Docrat, R., Brettenny, W., Holloway, J., Thiede, R., Debba, P., & Dudeni-Tlhone, N. (2023). A spatial model with vaccinations for COVID-19 in South Africa. Spatial Statistics, 58, Article 100792. Cited by 2.

3. Manjoo-Docrat, R. (2022). A spatio-stochastic model for the spread of infectious diseases. Journal of Theoretical Biology, 533, 110943.  Cited by 16.

4. Fabris-Rotelli, I., Holloway, J., Kimmie, Z., Archibald, S., Debba, P., Manjoo-Docrat, R., … Potgieter, A. (2022). A Spatial SEIR Model for COVID-19 in South Africa. Journal of Data Science, Statistics, and Visualisation, 2(7), 14–45.  Cited by 5.

Fangfang Tao | Chikungunya Virus | Best Researcher Award

Published on by Global Diseases Research

Prof. Dr. Fangfang Tao | Chikungunya Virus | Best Researcher Award 

Zhejiang Chinese Medical University | China

Prof. Dr. Fangfang Tao is a dedicated researcher at Zhejiang Chinese Medical University whose work spans integrative medicine, public health, and translational biomedical science. With a portfolio of 35 peer-reviewed publications and over 380 citations, Dr. Tao has established a growing scholarly presence supported by an h-index of 11, reflecting consistent influence and research quality. Her contributions often integrate traditional Chinese medical principles with modern clinical and epidemiological approaches, advancing evidence-based understanding of disease mechanisms, therapeutic strategies, and patient-centered health outcomes. Dr. Tao’s collaborative record is extensive, with partnerships involving more than 100 co-authors across national and international institutions, demonstrating her commitment to interdisciplinary inquiry and global scientific engagement. Her work contributes meaningfully to emerging health challenges by prioritizing rigorous methodology, culturally relevant medical insights, and innovative therapeutic frameworks. Through her research, Dr. Tao aims to bridge traditional medical knowledge with contemporary biomedical science to enhance clinical practice, inform health policy, and promote accessible, effective care. Her scholarly achievements underscore not only a strong trajectory in academic research but also a broader societal impact, as her studies support improved diagnostic approaches, better-targeted interventions, and enhanced patient well-being across diverse populations.

Profiles: Scopus | Google Scholar

Featured Publications

1. Niu, N., Zhang, J., Zhang, N., Mercado-Uribe, I., Tao, F., Han, Z., Pathak, S., … (2016). Linking genomic reorganization to tumor initiation via the giant cell cycle. Oncogenesis, 5(12), e281.
Cited by: 169

2. Tao, F., Tian, X., Ruan, S., Shen, M., & Zhang, Z. (2018). miR‐211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma. The FASEB Journal, 32(11), 6330–6343.
Cited by: 92

3. Tao, F., Tian, X., Lu, M., & Zhang, Z. (2018). A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c. Journal of Genetics and Genomics, 45(3), 137–145.
Cited by: 59

4. Tian, X., Tao, F., Zhang, B., Dong, J. T., & Zhang, Z. (2018). The miR‐203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK‐3β/β-catenin signal pathway. IUBMB Life, 70(3), 224–236.
Cited by: 42

5. Jiang, X., Cui, X., Xu, H., Liu, W., Tao, F., Shao, T., Pan, X., & Zheng, B. (2019). Whole genome sequencing of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from a wastewater treatment plant in China. Frontiers in Microbiology, 10, 1797.
Cited by: 34

Boon san Teoh | Antimicrobial Resistance | Best Researcher Award

Published on by Global Diseases Research

Ms. Boon san Teoh | Antimicrobial Resistance | Best Researcher Award 

Senior pharmacist | Singapore General Hospital | Singapore

Dr. Boon San Teoh is a distinguished clinician and researcher affiliated with Singapore General Hospital, Singapore’s leading medical institution recognized for excellence in clinical research and healthcare innovation. His professional expertise lies in infectious diseases and antimicrobial therapy, with a particular research interest in the clinical application and comparative effectiveness of advanced antibiotics such as daptomycin and linezolid in complex hospital settings. Dr. Teoh’s recent publication, “A Retrospective Study on the Use of Daptomycin and Linezolid in Singapore General Hospital,” featured in the journal Antibiotics (2025), reflects his commitment to improving patient outcomes through evidence-based medical practice and antimicrobial stewardship. His research contributions emphasize optimizing therapeutic interventions to address antibiotic resistance and ensure safer, more effective care. Beyond his scholarly endeavors, Dr. Teoh actively collaborates with multidisciplinary teams across microbiology, pharmacology, and hospital medicine, promoting integrated approaches to clinical challenges in infectious disease management. Through his engagement in research, mentorship, and collaborative healthcare improvement initiatives, Dr. Teoh contributes significantly to the advancement of medical science in Singapore and beyond. His academic integrity, clinical insight, and dedication to patient-centered research position him as a valuable contributor to global medical innovation, enhancing understanding of infectious disease dynamics and shaping strategies for better health outcomes worldwide.

Profiles: ORCID

Featured Publication

1. Teoh, B. S., Liew, Y. X., Wang, Y., Chung, S. J., & Tan, B. H. (2025, October 28). A retrospective study on the use of Daptomycin and Linezolid in Singapore General Hospital. Antibiotics, 14(11), 1088

Dr. Boon San Teoh’s research advances antimicrobial stewardship and patient safety through evidence-based evaluation of antibiotic therapies. His work at Singapore General Hospital contributes to optimizing clinical outcomes, reducing antimicrobial resistance, and strengthening global efforts toward sustainable healthcare innovation.